Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
38.02
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,942
Open
38.02
Bid (Size)
38.12 (1)
Ask (Size)
38.17 (1)
Prev. Close
38.02
Today's Range
38.02 - 38.02
52wk Range
36.17 - 54.93
Shares Outstanding
5,606,688,356
Dividend Yield
4.10%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
May 31, 2023
From
Pfizer Inc.
Via
Business Wire
Why Pfizer Stock Is Perking Up Today
May 31, 2023
Bargain hunters appear to be circling back to the beaten-down pharma stock today.
Via
The Motley Fool
Performance
YTD
-25.83%
-25.83%
1 Month
-3.03%
-3.03%
3 Month
-5.38%
-5.38%
6 Month
-24.16%
-24.16%
1 Year
-28.32%
-28.32%
More News
Read More
This Cannabis-Based Drug Has Outperformed Pfizer's Lyrica In Clinical Trials: A New Dawn For Diabetic Nerve Pain Management?
May 31, 2023
Via
Benzinga
Most Active Equity Options For Midday - Wednesday, May 31
May 31, 2023
Via
Talk Markets
2 Ultra-Safe Dividend Stocks to Load Up On Right Now
May 31, 2023
Via
The Motley Fool
Pfizer Unusual Options Activity For May 30
May 30, 2023
Via
Benzinga
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Tuesday Trading
May 30, 2023
Via
Investor Brand Network
One man’s journey with advanced prostate cancer
May 30, 2023
Via
Brandpoint
Does Pfizer Have a Weight-Loss Pill That's Better Than Ozempic?
May 31, 2023
Via
The Motley Fool
2 Newly Minted AI Stocks to Buy Right Now
May 31, 2023
Via
The Motley Fool
3 Stocks Worth Buying at 52-Week Lows
May 30, 2023
Via
MarketBeat
How Pfizer's First-Ever Approach In Hemophilia Treatment Paid Off
May 30, 2023
Via
Investor's Business Daily
Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
May 30, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer's Heading for a Patent Cliff. Is the Stock Still a Buy?
May 30, 2023
Via
The Motley Fool
5 Value Stocks In The Healthcare Sector
May 29, 2023
Via
Benzinga
The 3 Best Healthcare Stocks to Buy for June 2023
May 29, 2023
Via
InvestorPlace
The Top Healthcare Stocks to Buy With $100
May 29, 2023
Via
The Motley Fool
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income
May 27, 2023
Via
The Motley Fool
MarketBeat Week in Review – 5/22 - 5/26
May 27, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Interest Rates
3 No-Brainer Stocks to Buy for Under $100 Right Now
May 27, 2023
Via
The Motley Fool
Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected
May 26, 2023
Via
Investor's Business Daily
Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex
May 26, 2023
Via
SBWire
Exposures
Climate
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
May 26, 2023
Via
Benzinga
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
May 26, 2023
Via
FinancialNewsMedia
Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases
May 26, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.